Natera Inc
NASDAQ:NTRA

Watchlist Manager
Natera Inc Logo
Natera Inc
NASDAQ:NTRA
Watchlist
Price: 167.26 USD -1.24% Market Closed
Market Cap: 20.7B USD
Have any thoughts about
Natera Inc?
Write Note

Intrinsic Value

The intrinsic value of one NTRA stock under the Base Case scenario is 56.65 USD. Compared to the current market price of 167.26 USD, Natera Inc is Overvalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NTRA Intrinsic Value
56.65 USD
Overvaluation 66%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Natera Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NTRA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NTRA?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Natera Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Natera Inc

Provide an overview of the primary business activities
of Natera Inc.

What unique competitive advantages
does Natera Inc hold over its rivals?

What risks and challenges
does Natera Inc face in the near future?

Has there been any significant insider trading activity
in Natera Inc recently?

Summarize the latest earnings call
of Natera Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Natera Inc.

Provide P/S
for Natera Inc.

Provide P/E
for Natera Inc.

Provide P/OCF
for Natera Inc.

Provide P/FCFE
for Natera Inc.

Provide P/B
for Natera Inc.

Provide EV/S
for Natera Inc.

Provide EV/GP
for Natera Inc.

Provide EV/EBITDA
for Natera Inc.

Provide EV/EBIT
for Natera Inc.

Provide EV/OCF
for Natera Inc.

Provide EV/FCFF
for Natera Inc.

Provide EV/IC
for Natera Inc.

Show me price targets
for Natera Inc made by professional analysts.

What are the Revenue projections
for Natera Inc?

How accurate were the past Revenue estimates
for Natera Inc?

What are the Net Income projections
for Natera Inc?

How accurate were the past Net Income estimates
for Natera Inc?

What are the EPS projections
for Natera Inc?

How accurate were the past EPS estimates
for Natera Inc?

What are the EBIT projections
for Natera Inc?

How accurate were the past EBIT estimates
for Natera Inc?

Compare the revenue forecasts
for Natera Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Natera Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Natera Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Natera Inc compared to its peers.

Compare the P/E ratios
of Natera Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Natera Inc with its peers.

Analyze the financial leverage
of Natera Inc compared to its main competitors.

Show all profitability ratios
for Natera Inc.

Provide ROE
for Natera Inc.

Provide ROA
for Natera Inc.

Provide ROIC
for Natera Inc.

Provide ROCE
for Natera Inc.

Provide Gross Margin
for Natera Inc.

Provide Operating Margin
for Natera Inc.

Provide Net Margin
for Natera Inc.

Provide FCF Margin
for Natera Inc.

Show all solvency ratios
for Natera Inc.

Provide D/E Ratio
for Natera Inc.

Provide D/A Ratio
for Natera Inc.

Provide Interest Coverage Ratio
for Natera Inc.

Provide Altman Z-Score Ratio
for Natera Inc.

Provide Quick Ratio
for Natera Inc.

Provide Current Ratio
for Natera Inc.

Provide Cash Ratio
for Natera Inc.

What is the historical Revenue growth
over the last 5 years for Natera Inc?

What is the historical Net Income growth
over the last 5 years for Natera Inc?

What is the current Free Cash Flow
of Natera Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Natera Inc.

Business Breakdown

Natera Inc. is a leading genomics company that specializes in genetic testing and precision medicine, aiming to revolutionize healthcare through advanced DNA analysis. Founded in 2004 and headquartered in Austin, Texas, Natera focuses on reproductive health, oncology, and organ transplant management, providing invaluable insights that help doctors make informed decisions for their patients. Its flagship products include non-invasive prenatal testing (NIPT), which has gained significant traction for its ability to assess fetal health with remarkable accuracy, along with tests for hereditary cancer risk and monitoring treatment response in cancer patients. By harnessing the power of next-gener...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Natera Inc

Current Assets 1.3B
Cash & Short-Term Investments 922.3m
Receivables 306.9m
Other Current Assets 93.4m
Non-Current Assets 268.4m
PP&E 230m
Other Non-Current Assets 38.4m
Current Liabilities 301.4m
Accounts Payable 27.8m
Accrued Liabilities 159.4m
Short-Term Debt 80.5m
Other Current Liabilities 33.7m
Non-Current Liabilities 411m
Long-Term Debt 286.5m
Other Non-Current Liabilities 124.5m
Efficiency

Earnings Waterfall
Natera Inc

Revenue
1.5B USD
Cost of Revenue
-648.6m USD
Gross Profit
883.4m USD
Operating Expenses
-1.1B USD
Operating Income
-242.1m USD
Other Expenses
27.4m USD
Net Income
-214.7m USD

Free Cash Flow Analysis
Natera Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In Q3 2024, Natera reported a remarkable 64% year-over-year revenue increase, reaching $439.8 million, driven by a 24% rise in test volumes. Signatera clinical units surged by over 48,000 units year-on-year. With gross margins at a record 62%, the company generated $34.5 million in cash. Natera now anticipates full-year revenues between $1.61 billion and $1.64 billion, reflecting a growth rate of about 50%. Looking ahead, they aim to maintain similar test volumes in 2025 while focusing on expanding their oncology presence and enhancing service capabilities.

What is Earnings Call?
Fundamental Scores

NTRA Profitability Score
Profitability Due Diligence

Natera Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

33/100
Profitability
Score

Natera Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

NTRA Solvency Score
Solvency Due Diligence

Natera Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Negative Net Debt
65/100
Solvency
Score

Natera Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NTRA Price Targets Summary
Natera Inc

Wall Street analysts forecast NTRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NTRA is 174.82 USD with a low forecast of 136.35 USD and a high forecast of 219.45 USD.

Lowest
Price Target
136.35 USD
18% Downside
Average
Price Target
174.82 USD
5% Upside
Highest
Price Target
219.45 USD
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NTRA?

Click here to dive deeper.

Dividends

Natera Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NTRA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NTRA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

NTRA News

Other Videos

Profile

Natera Inc Logo
Natera Inc

Country

United States of America

Industry

Biotechnology

Market Cap

20.8B USD

Dividend Yield

0%

Description

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in Austin, Texas and currently employs 2,670 full-time employees. The company went IPO on 2015-07-02. The Company’s cell-free deoxyribonucleic acid (DNA) or (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The firm's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantation Genetics (Spectrum), Anora Miscarriage Test (Anora), Non-Invasive Paternity Testing (PAT) and Prospera. The firm also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology.

Contact

TEXAS
Austin
13011 Mccallen Pass, Building A Suite 100
+16502499090.0
www.natera.com

IPO

2015-07-02

Employees

2 670

Officers

Co-Founder & Executive Chairman
Dr. Matthew Rabinowitz Ph.D.
CEO & Director
Mr. Steven Leonard Chapman
Chief Financial Officer
Mr. Michael B. Brophy M.B.A.
Secretary & Chief Legal Officer
Mr. Daniel Rabinowitz L.L.M.
President & Chief Business Officer
Mr. John Fesko
Co-Founder & Director
Mr. Jonathan Sheena M.Eng.
Show More
Chief Accounting Officer
Ms. Olesya A. Anisimova CPA
Chief Technology Officer
Mr. Rishi Kacker
Chief Scientific Officer
Mr. Eric A. Evans
Chief Compliance & Privacy Officer
Mr. Jerry Diffley
Show Less

See Also

Discover More
What is the Intrinsic Value of one NTRA stock?

The intrinsic value of one NTRA stock under the Base Case scenario is 56.65 USD.

Is NTRA stock undervalued or overvalued?

Compared to the current market price of 167.26 USD, Natera Inc is Overvalued by 66%.

Back to Top